Document is current
Any future updates will be listed below
-
Authors
Gopalakrishna, Harish
Chalasani, Naga https://orcid.org/0000-0003-4082-3178
- License Information
-
More Information
Article History
First Online: 3 September 2024
Declarations
:
: Not applicable.
: Naga Chalasani has ongoing paid consulting activities (or had in preceding 12 months) with Madrigal, Zydus, Altimmune, Ipsen, GSK, Pfizer and Merck. He has grant support from Exact Sciences. He has equity in Avant Sante, a contract research organization. These activities are not directly or significantly related to this paper. Harish Gopalakrishna has no conflict of interest to disclose.
: The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Free to read: This content has been made available to all.
